Document is current

Any future updates will be listed below

Correction: Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma

Crossref DOI link: https://doi.org/10.1038/s41598-025-21843-4

Published Online: 2025-10-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark